Publications in collaboration with researchers from Hospital Universitario Virgen del Rocío (2)

2025

  1. SOS1 inhibitor BI-3406 shows in vivo antitumor activity akin to genetic ablation and synergizes with a KRASG12D inhibitor in KRAS LUAD

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 122, Núm. 11

2022

  1. Critical Requirement of SOS1 for Development of BCR/ABL-Driven Chronic Myelogenous Leukemia

    Cancers, Vol. 14, Núm. 16